A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.
To be considered clinically relevant, a biomarker must have a high DA; [32] that is, it must have high sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) ...